• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在非传统模型中,针对克柔念珠菌感染的抗真菌疗效与体外酵母药敏谱相关。

Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.

机构信息

Mycology Reference Laboratory, National Centre for Microbiology, Instituto de Salud Carlos III, Madrid, Spain.

出版信息

PLoS One. 2013;8(3):e60047. doi: 10.1371/journal.pone.0060047. Epub 2013 Mar 28.

DOI:10.1371/journal.pone.0060047
PMID:23555877
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3610750/
Abstract

The incidence of opportunistic fungal infections has increased in recent decades due to the growing proportion of immunocompromised patients in our society. Candida krusei has been described as a causative agent of disseminated fungal infections in susceptible patients. Although its prevalence remains low among yeast infections (2-5%), its intrinsic resistance to fluconazole makes this yeast important from epidemiologic aspects. Non mammalian organisms are feasible models to study fungal virulence and drug efficacy. In this work we have used the lepidopteran Galleria mellonella and the nematode Caenorhabditis elegans as models to assess antifungal efficacy during infection by C. krusei. This yeast killed G. mellonella at 25, 30 and 37°C and reduced haemocytic density. Infected larvae melanized in a dose-dependent manner. Fluconazole did not protect against C. krusei infection, in contrast to amphotericin B, voriconazole or caspofungin. However, the doses of these antifungals required to obtain larvae protection were always higher during C. krusei infection than during C. albicans infection. Similar results were found in the model host C. elegans. Our work demonstrates that non mammalian models are useful tools to investigate in vivo antifungal efficacy and virulence of C. krusei.

摘要

近年来,由于我们社会中免疫功能低下患者的比例不断增加,机会性真菌感染的发病率有所增加。克柔假丝酵母菌已被描述为易感患者播散性真菌感染的病原体。尽管其在酵母感染中的患病率(2-5%)仍然较低,但它对氟康唑的固有耐药性使其在流行病学方面具有重要意义。非哺乳动物生物是研究真菌毒力和药物疗效的可行模型。在这项工作中,我们使用鳞翅目昆虫家蚕和线虫秀丽隐杆线虫作为模型,评估克柔假丝酵母菌感染期间的抗真菌疗效。该酵母在 25、30 和 37°C 时可杀死家蚕并降低血淋巴细胞密度。受感染的幼虫以剂量依赖性方式黑化。氟康唑不能预防克柔假丝酵母菌感染,而两性霉素 B、伏立康唑或卡泊芬净则可以。然而,与白色念珠菌感染相比,在克柔假丝酵母菌感染期间,获得幼虫保护所需的这些抗真菌药物剂量始终更高。在模式宿主秀丽隐杆线虫中也发现了类似的结果。我们的工作表明,非哺乳动物模型是研究克柔假丝酵母菌体内抗真菌疗效和毒力的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/d46b387c3379/pone.0060047.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/9be191e01820/pone.0060047.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/ab5b14b524d5/pone.0060047.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/26b14a3f6ca3/pone.0060047.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/af149bf342f3/pone.0060047.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/9dc996ceda9b/pone.0060047.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/8c660129fe56/pone.0060047.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/dca5fded901d/pone.0060047.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/e9700c0e1017/pone.0060047.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/229a0938b853/pone.0060047.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/d46b387c3379/pone.0060047.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/9be191e01820/pone.0060047.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/ab5b14b524d5/pone.0060047.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/26b14a3f6ca3/pone.0060047.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/af149bf342f3/pone.0060047.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/9dc996ceda9b/pone.0060047.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/8c660129fe56/pone.0060047.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/dca5fded901d/pone.0060047.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/e9700c0e1017/pone.0060047.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/229a0938b853/pone.0060047.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ba4/3610750/d46b387c3379/pone.0060047.g010.jpg

相似文献

1
Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.在非传统模型中,针对克柔念珠菌感染的抗真菌疗效与体外酵母药敏谱相关。
PLoS One. 2013;8(3):e60047. doi: 10.1371/journal.pone.0060047. Epub 2013 Mar 28.
2
Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.伏立康唑(UK-109,496)、氟康唑和两性霉素B对中性粒细胞减少豚鼠模型血源性克柔念珠菌感染的抗真菌活性。
J Chemother. 1999 Feb;11(1):34-9. doi: 10.1179/joc.1999.11.1.34.
3
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
4
Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.黄粉虫作为研究植入物相关真菌感染的替代体内模型。
J Orthop Res. 2023 Nov;41(11):2547-2559. doi: 10.1002/jor.25572. Epub 2023 Apr 30.
5
Antifungal resistance: the clinical front.抗真菌耐药性:临床前沿
Oncology (Williston Park). 2004 Dec;18(14 Suppl 13):15-22.
6
Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei.艾沙康唑、伏立康唑和氟康唑在热带念珠菌和克柔念珠菌播散性感染的暂时性中性粒细胞减少小鼠模型中的疗效。
J Antimicrob Chemother. 2009 Jan;63(1):161-6. doi: 10.1093/jac/dkn431. Epub 2008 Nov 13.
7
Virulence of Candida haemulonii complex in Galleria mellonella and efficacy of classical antifungal drugs: a comparative study with other clinically relevant non-albicans Candida species.半滑舌鳎鱼中假丝酵母复合种的毒力和经典抗真菌药物的疗效:与其他临床相关的非白念珠菌假丝酵母种的比较研究。
FEMS Yeast Res. 2018 Nov 1;18(7). doi: 10.1093/femsyr/foy082.
8
Efficacy of triazoles in a murine disseminated infection by Candida krusei.三唑类药物对克鲁斯念珠菌所致小鼠播散性感染的疗效
Antimicrob Agents Chemother. 2009 Aug;53(8):3585-8. doi: 10.1128/AAC.00293-09. Epub 2009 May 26.
9
Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study.墨西哥蒙特雷收集的念珠菌血流分离株的物种分布及对七种抗真菌药物敏感性的趋势:一项为期三年(2004年至2007年)的监测研究结果
J Clin Microbiol. 2008 Sep;46(9):2902-5. doi: 10.1128/JCM.00937-08. Epub 2008 Jul 16.
10
Voriconazole and fluconazole susceptibility of Candida isolates.念珠菌分离株对伏立康唑和氟康唑的敏感性
J Med Microbiol. 2002 Jun;51(6):479-483. doi: 10.1099/0022-1317-51-6-479.

引用本文的文献

1
and Antifungal Efficacy and Safety of the Def2.1 Peptide against the Neglected and Drug-Resistant Pathogen.Def2.1肽对被忽视的耐药病原体的抗真菌疗效和安全性
ACS Bio Med Chem Au. 2025 May 13;5(4):620-636. doi: 10.1021/acsbiomedchemau.5c00020. eCollection 2025 Aug 20.
2
New Therapeutic Options for Fusariosis: A Patent Review (2008-2023).镰刀菌病的新治疗选择:专利综述(2008 - 2023年)
J Fungi (Basel). 2025 Jun 18;11(6):463. doi: 10.3390/jof11060463.
3
(Greater Wax Moth) as a Reliable Animal Model to Study the Efficacy of Nanomaterials in Fighting Pathogens.

本文引用的文献

1
The non-mammalian host Galleria mellonella can be used to study the virulence of the fungal pathogen Candida tropicalis and the efficacy of antifungal drugs during infection by this pathogenic yeast.无脊椎动物宿主地中海实蝇可用于研究真菌病原体热带假丝酵母的毒力和这种致病性酵母感染期间抗真菌药物的疗效。
Med Mycol. 2013 Jul;51(5):461-72. doi: 10.3109/13693786.2012.737031. Epub 2012 Nov 21.
2
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug.只需一种药物就能发挥多种作用:两性霉素B作为抗真菌和免疫调节药物。
Front Microbiol. 2012 Aug 8;3:286. doi: 10.3389/fmicb.2012.00286. eCollection 2012.
3
(大蜡螟)作为研究纳米材料对抗病原体功效的可靠动物模型。
Nanomaterials (Basel). 2025 Jan 3;15(1):67. doi: 10.3390/nano15010067.
4
Toxicological Assessment of 2-Hydroxychalcone-Mediated Photodynamic Therapy: Comparative In Vitro and In Vivo Approaches.2-羟基查尔酮介导的光动力疗法的毒理学评估:体外和体内比较研究方法
Pharmaceutics. 2024 Nov 26;16(12):1523. doi: 10.3390/pharmaceutics16121523.
5
Candida krusei (Pichia kudriavzevii) multilocus sequence typing and antifungal susceptibility profile in Cameroon.喀麦隆克鲁斯念珠菌(库德里阿兹威毕赤酵母)多位点序列分型及抗真菌药敏谱分析
Braz J Microbiol. 2025 Mar;56(1):383-393. doi: 10.1007/s42770-024-01569-7. Epub 2024 Dec 9.
6
Bioprospecting, Synergistic Antifungal and Toxicological Aspects of the Hydroxychalcones and Their Association with Azole Derivates against spp. for Treating Vulvovaginal Candidiasis.羟基查耳酮的生物勘探、协同抗真菌及毒理学方面及其与唑类衍生物联合抗**(此处原文缺失相关真菌名称)**治疗外阴阴道念珠菌病的研究
Pharmaceutics. 2024 Jun 21;16(7):843. doi: 10.3390/pharmaceutics16070843.
7
Infection Modulates Antimicrobial Peptides and Stress Management Gene Expression in the Invertebrate Biomodel .感染调节无脊椎动物生物模型中的抗菌肽和应激管理基因表达。
J Fungi (Basel). 2023 Oct 27;9(11):1053. doi: 10.3390/jof9111053.
8
Antifungal Resistance Profile, Biofilm Formation, and Virulence Factor Production in Candida krusei Isolates From HIV-Infected Patients in Cameroon.喀麦隆HIV感染患者分离出的克鲁斯念珠菌的抗真菌耐药性、生物膜形成及毒力因子产生情况
Cureus. 2023 Aug 27;15(8):e44213. doi: 10.7759/cureus.44213. eCollection 2023 Aug.
9
Antifungal Exposure and Resistance Development: Defining Minimal Selective Antifungal Concentrations and Testing Methodologies.抗真菌药物暴露与耐药性发展:定义最小选择性抗真菌浓度及检测方法
Front Fungal Biol. 2022 Jun 13;3:918717. doi: 10.3389/ffunb.2022.918717. eCollection 2022.
10
Development of Echinocandin Resistance in : An Emergent, Widespread, and Opportunistic Fungal Pathogen.棘白菌素耐药性在(某真菌名称未给出)中的发展:一种新兴、广泛传播且具机会致病性的真菌病原体 。
J Fungi (Basel). 2023 Aug 18;9(8):859. doi: 10.3390/jof9080859.
EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST).
EUCAST 技术说明:EUCAST 确诊文件 EDef 7.2:抗真菌药物检测酵母菌肉汤稀释最低抑菌浓度的方法(EUCAST-AFST)。
Clin Microbiol Infect. 2012 Jul;18(7):E246-7. doi: 10.1111/j.1469-0691.2012.03880.x. Epub 2012 May 8.
4
Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.一项西班牙多中心前瞻性调查:血流真菌感染的流行病学、菌种分布和体外抗真菌药敏性。
J Antimicrob Chemother. 2012 May;67(5):1181-7. doi: 10.1093/jac/dks019. Epub 2012 Feb 20.
5
Selecting an invertebrate model host for the study of fungal pathogenesis.选择用于真菌致病机制研究的无脊椎动物模型宿主。
PLoS Pathog. 2012 Feb;8(2):e1002451. doi: 10.1371/journal.ppat.1002451. Epub 2012 Feb 2.
6
The role of mycelium production and a MAPK-mediated immune response in the C. elegans-Fusarium model system.菌丝体产生和一个 MAPK 介导的免疫反应在秀丽隐杆线虫-镰刀菌模型系统中的作用。
Med Mycol. 2012 Jul;50(5):488-96. doi: 10.3109/13693786.2011.648217. Epub 2012 Jan 9.
7
Of model hosts and man: using Caenorhabditis elegans, Drosophila melanogaster and Galleria mellonella as model hosts for infectious disease research.模式宿主与人类:利用秀丽隐杆线虫、黑腹果蝇和桔小实蝇作为传染病研究的模式宿主。
Adv Exp Med Biol. 2012;710:11-7. doi: 10.1007/978-1-4419-5638-5_2.
8
Fusarium pathogenesis investigated using Galleria mellonella as a heterologous host.利用黄粉虫作为异源宿主研究镰刀菌的发病机制。
Fungal Biol. 2011 Dec;115(12):1279-89. doi: 10.1016/j.funbio.2011.09.005. Epub 2011 Oct 4.
9
[General epidemiology of invasive fungal disease].[侵袭性真菌病的一般流行病学]
Enferm Infecc Microbiol Clin. 2012 Feb;30(2):90-8. doi: 10.1016/j.eimc.2011.09.004. Epub 2011 Nov 12.
10
Catch me if you can: phagocytosis and killing avoidance by Cryptococcus neoformans.若你能,便来抓我:新型隐球菌的吞噬作用及逃避杀伤机制
FEMS Immunol Med Microbiol. 2012 Mar;64(2):147-61. doi: 10.1111/j.1574-695X.2011.00871.x.